https://yoda.yale.edu/clinical-trial/nct02926430-a-randomized-double-blind-first-in-human-phase-1-study-to-evaluate-the-safety-tolerability-and-immunogenicity-of-two-vaccinations-of-ad26-rsv-pref-one-year-apart-in-adults-aged-60-yea/
NCT02926430 - A Randomized, Double-blind, First-in-Human Phase 1 Study to Evaluate the Safety,...